TrialScope Announces Opening of New Headquarters Location
JERSEY CITY, N.J., June 3, 2015
TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced that it has relocated its headquarters to a larger space that accommodates the rapid growth the company has experienced in recent years and the expected growth in the coming years.
The new headquarters location, situated along the Hudson River in the Harborside Financial Center in Jersey City, New Jersey, is still within the New York City metropolitan area. The space offers almost 12,000 square feet of professional space that supports the growing team as well as expanded common meeting spaces.
Mike Forgash, CEO, TrialScope, commented, “Our team and customer base are both expanding pretty quickly and we needed additional space to support such growth. In addition, our Rapid Path to Compliance engagement methodology demands that we have space for frequent customer and partner interactions. We need the space to host important cross-industry conversations such as best practices for validating SaaS solutions, the development of a Clinical Trial Disclosure Maturity Model and other topics that have strategic value to our customers. We also wanted to stay in the life sciences corridor and the new space allows us to do all of these things without compromise.”
Richard Aguinaldo, Chief Financial Officer, noted, “Compliance with complex clinical trial disclosure requirements is increasingly important to sponsors. For that reason, TrialScope is garnering a great deal of interest in the marketplace. The new location will enable us to continue to attract leading talent to meet future recruiting needs. The headquarters move represents a natural progression that aligns with our strategy while supporting our current and future space requirements.”
The address for the new location is: Harborside Financial Center, Plaza Five, Suite 2900, Jersey City New Jersey 07311.
TrialScope simplifies the complexities of clinical transparency management. TrialScope is a proven solution that has been implemented successfully and rigorously tested in the most complex environments with solutions that are currently implemented at 12 of the top 30 global clinical trial sponsors, including 6 of the top 10. The company’s market-driven solution and expertise enable sponsors to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater compliance. TrialScope technology is deployed on a SaaS platform hosted in a private cloud.